New York State Common Retirement Fund Exelixis, Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Exelixis, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 175,717 shares of EXEL stock, worth $6.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
175,717
Previous 213,717 17.78%
Holding current value
$6.16 Million
Previous $4.8 Million 5.04%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$21.96 - $27.6 $834,480 - $1.05 Million
-38,000 Reduced 17.78%
175,717 $4.56 Million
Q2 2024

Jul 31, 2024
SELL
$20.34 - $23.73 $180,314 - $210,366
-8,865 Reduced 3.98%
213,717 $4.8 Million
Q1 2024

May 07, 2024
SELL
$20.17 - $23.93 $1.03 Million - $1.22 Million
-51,069 Reduced 18.66%
222,582 $5.28 Million
Q4 2023

Feb 01, 2024
SELL
$19.25 - $24.13 $365,653 - $458,349
-18,995 Reduced 6.49%
273,651 $6.57 Million
Q3 2023

Nov 07, 2023
SELL
$19.04 - $22.74 $879,038 - $1.05 Million
-46,168 Reduced 13.63%
292,646 $6.39 Million
Q2 2023

Aug 07, 2023
SELL
$18.17 - $20.48 $52,983 - $59,719
-2,916 Reduced 0.85%
338,814 $6.48 Million
Q1 2023

May 02, 2023
SELL
$16.3 - $19.41 $10.7 Million - $12.7 Million
-655,746 Reduced 65.74%
341,730 $6.63 Million
Q4 2022

Jan 30, 2023
BUY
$14.96 - $17.39 $352,906 - $410,230
23,590 Added 2.42%
997,476 $16 Million
Q3 2022

Nov 08, 2022
SELL
$15.68 - $22.27 $202,397 - $287,461
-12,908 Reduced 1.31%
973,886 $15.3 Million
Q2 2022

Aug 04, 2022
SELL
$17.44 - $23.16 $134,968 - $179,235
-7,739 Reduced 0.78%
986,794 $20.5 Million
Q1 2022

May 05, 2022
SELL
$17.03 - $22.67 $199,148 - $265,102
-11,694 Reduced 1.16%
994,533 $22.5 Million
Q4 2021

Feb 02, 2022
BUY
$15.84 - $21.88 $1.53 Million - $2.12 Million
96,872 Added 10.65%
1,006,227 $18.4 Million
Q3 2021

Nov 02, 2021
BUY
$16.3 - $21.14 $53,268 - $69,085
3,268 Added 0.36%
909,355 $19.2 Million
Q2 2021

Aug 02, 2021
SELL
$17.95 - $25.56 $4.2 Million - $5.98 Million
-233,994 Reduced 20.52%
906,087 $16.5 Million
Q1 2021

May 11, 2021
SELL
$20.53 - $25.22 $1.54 Million - $1.9 Million
-75,200 Reduced 6.19%
1,140,081 $25.8 Million
Q4 2020

Feb 08, 2021
BUY
$18.39 - $24.8 $738,671 - $996,141
40,167 Added 3.42%
1,215,281 $24.4 Million
Q3 2020

Nov 05, 2020
SELL
$20.67 - $26.94 $940,485 - $1.23 Million
-45,500 Reduced 3.73%
1,175,114 $28.7 Million
Q2 2020

Aug 07, 2020
SELL
$16.46 - $27.42 $2.57 Million - $4.28 Million
-156,114 Reduced 11.34%
1,220,614 $29 Million
Q1 2020

May 06, 2020
BUY
$14.46 - $21.8 $244,634 - $368,812
16,918 Added 1.24%
1,376,728 $23.7 Million
Q4 2019

Feb 05, 2020
SELL
$15.15 - $18.89 $74,235 - $92,561
-4,900 Reduced 0.36%
1,359,810 $24 Million
Q3 2019

Nov 07, 2019
SELL
$17.68 - $22.65 $457,912 - $586,635
-25,900 Reduced 1.86%
1,364,710 $24.1 Million
Q2 2019

Aug 09, 2019
BUY
$18.93 - $24.75 $2.46 Million - $3.22 Million
130,185 Added 10.33%
1,390,610 $29.7 Million
Q1 2019

May 08, 2019
BUY
$19.6 - $24.76 $1.4 Million - $1.77 Million
71,485 Added 6.01%
1,260,425 $30 Million
Q4 2018

Feb 08, 2019
BUY
$13.65 - $21.8 $8.32 Million - $13.3 Million
609,740 Added 105.27%
1,188,940 $23.4 Million
Q3 2018

Nov 07, 2018
SELL
$15.87 - $22.4 $2.51 Million - $3.54 Million
-157,986 Reduced 21.43%
579,200 $10.3 Million
Q2 2018

Aug 10, 2018
BUY
$18.56 - $22.45 $7,832 - $9,473
422 Added 0.06%
737,186 $15.9 Million
Q1 2018

May 10, 2018
SELL
$22.15 - $31.89 $624,519 - $899,138
-28,195 Reduced 3.69%
736,764 $16.3 Million
Q4 2017

Feb 13, 2018
BUY
$24.23 - $30.93 $295,484 - $377,191
12,195 Added 1.62%
764,959 $23.3 Million
Q3 2017

Nov 06, 2017
BUY
$23.35 - $29.24 $1.78 Million - $2.23 Million
76,367 Added 11.29%
752,764 $18.2 Million
Q2 2017

Aug 11, 2017
BUY
N/A
676,397
676,397 $16.7 Million

Others Institutions Holding EXEL

# of Institutions
495
Shares Held
244M
Call Options Held
2.4M
Put Options Held
2.21M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.3B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email